Page 102 - Taiwan Food and Drug Administration 2016 Annual Report

Taiwan Food and Drug Adminstration

Summit meeting of the Working Group on Safety Administration
Figure 2-8-14
and Research and Development of Medicinal Products
b. TFDA participated in the 2015 International Meeting for the Prevention of Substance Abuse in
Mainland China, conducting of?cial dialogue and exchanged information with leading experts
of the Asia Paci?c region in the ?eld of substance abuse as well as discussing various topics
related to the epidemiology, treatment, and prevention of drug abuse in the Asia Paci?c region.

2. Border Control Information Notification
TFDA and its Mainland China counterpart have established contact windows to notify
nonconforming food products information in order to facilitate effective response and handling
of these cases. 941 cases were reported by both parties in 2015. Nonconforming food exported
from Mainland China to Taiwan were either returned or destroyed. Incidents of food exported
to Mainland China from Taiwan that failed to conform to Taiwan's regulations were reported to
the responsible local health bureaus. The local health bureaus would take actions against the
violating cases. Consultations were provided to businesses that food exports must comply with
the regulations of the trading counterparty as well.

3. Harmonization of Regulations and Standards
(1) Cross-Strait notification for addenda and revisions to regulations such as the food additive
standards and food safety and sanitation standards was conducted through the contact
window in order to promote exchange of relevant opinions and achieve mutual understanding.
From the time of its establishment to the end of 2015, in total, both sides made 24 noti?cation
on food additive standards and eight noti?cation on food safety and sanitation standards.
(2) In 2015, comparisons and harmonization of test methods and standards were conducted
for common tests performed in both Taiwan and Mainland China, with seven tests listed in
the Pharmacopoeia compared and harmonized accordingly. The aim of this activity was to
establish the feasibility of streamlining or exempting medical product testing requirements for
Taiwan and Mainland China.
th
(3) The 4 Cross-Strait Exchange Conference on Medicine and Medical Products Testing
Techniques (Figure 2-8-15) was held in Taipei during October 19 to 20, 2015. The Conference
discussed 18 topics that included medicinal products, medical devices, health foods,
cosmetics, and laboratory accreditation, and was helpful to harmonize medical product testing
standards and technologies in Taiwan and Mainland China.
4. Research and Development Partnerships
(1) Expediting the Market Release of Products Made in Taiwan
a. Since 2012, Taiwan had continued to propose to the China Food and Drug Administration (CFDA)
to allow medical devices that were already approved by Taiwan to be reviewed by provincial
100 or municipal food and drug administrations. On 2015, the Fujian Provincial Food and Drug